Jeffrey N. Peterson
Jeffrey N. Peterson has served as Chairman of Pressure Biosciences, Inc. (OTCQB:PBIO) since rebuilding its Board in 2012, and as a Board Member since 2011. He works very closely with the CEO on numerous strategy, partnering, debt and equity funding (private, public, S-1), up listing, and acquisition initiatives. PBIO is an innovative platform technology company leading in the development and sale of broadly enabling, high-pressure-based instruments, consumables, and specialty testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries. Their proprietary platform technologies include pressure cycling for optimized sample preparation before analysis; high-pressure disaggregation and refolding of proteins for optimal therapeutic effectiveness; and efficient and scalable manufacture of nano-emulsions with precisely controlled and ultra-low droplet size to serve diverse large markets with improved delivery and bioavailability of active therapeutics, nutrients and other products.
In 2018, Mr. Peterson accepted the role of Board Chairman, to assist the CEO and team with funding and relaunch of an innovative, low-cost CT medical imaging technology, for Imaging3, Inc. (OTCQB:IGNG) as it emerged from bankruptcy. After bringing critical Board, R&D and prospective manufacturing resources to IGNG, Mr. Peterson ultimately assessed that IGNG investors would be best served by an opportunistic exit, and utilized the entity to execute a reverse merger taking a cannabis company public.
Mr. Peterson is cofounder and CEO of Target Discovery, Inc., a mass-spectrometry-based personalized medicine diagnostics company focused on high-value treatment guidance applications, innovating proteomics and analytical technology solutions identifying and leveraging specific modification states (isoforms) of proteins critical in biochemical pathway control and biomarker utility. Mr. Peterson serves on the Board of MassWerx, Inc., a TDI minority-owned spin-off company, extending TDI’s capabilities and resources into food and beverage, agricultural, environmental and other testing applications, utilizing simple and robust mass spec platforms coupled with innovative AI/ML strategies.
Mr. Peterson is also Chairman & CEO of Veritomyx, Inc., a TDI subsidiary innovatively designed for equity-driven professionals. Veritomyx provides high-performance cloud computing SaaS solutions, delivering advanced signal processing to provide breakthrough accuracy in peptide, protein, isoform and metabolite identification and characterization, achieving revolutionary extensions of mass spectrometry and life science R&D capabilities.
Mr. Peterson brings broad executive general management, multi-functional, multi-business and international experience to these roles. Prior to founding Target Discovery, he served as CEO of Sharpe, Peterson, Ocheltree & Associates, an international business development consulting firm assisting Fortune 500 and many smaller firms in business expansion and strategy.
Mr. Peterson previously held key management roles over 9 years in Abbott Laboratories’ Diagnostics and International (Pharmaceuticals, Hospital Products, Nutritionals, Consumer) businesses, finally as CEO and GM of Abbott South Africa. In this role, he doubled the sales and tripled the income of this 50-year-old business in 3.5 years, during the exciting tumult of Mandela’s transition from prisoner to President. Mr. Peterson played an earlier pivotal management role in Abbott’s successful introduction and support of multiple new diagnostics instrument and reagent systems in the history-making X-System series, including the IMx (the highest global sales diagnostic system to that time).
Prior to Abbott, Mr. Peterson’s experience included 11 years with General Electric’s Engineered Materials (silicones, superabrasive industrial diamonds and tungsten carbide, circuit board laminates, rechargeable batteries, wire and cable, engineering ceramics) and Plastics businesses, spanning roles in strategic planning, business development, technology licensing, marketing/sales, quality, process engineering, operations and R&D.
He completed the Entrepreneurship curriculum and holds BSChemE and MSChemE degrees from MIT. He holds six issued US and many related international patents, and has authored multiple peer-reviewed articles in scientific journals.
Mr. Peterson currently serves on the Advisory Board for the California Technology Council, which innovates to advance California’s primacy in all forms of technology, applications, systems and infrastructure. He is Chair Emeritus of the BayBio Institute, a non-profit organization that served the CA life science community and fostered a highly successful Fellows entrepreneurship development program. He served for 12 years on the Board of BayBio, a trade association for the CA life sciences industry, and was instrumental in directing the separation and strategic direction of the 501(c)3 Institute, and in the 2015 merger of BayBio with the California Healthcare Institute to form CA Life Sciences.
Mr. Peterson participated in founding and served as an active leader in the Coalition for 21st Century Medicine, and in BIO’s Personalized Medicine & Diagnostics Group. He has regularly contributed as a keynote, speaker or panelist on life sciences/healthcare policy, technology, innovation, workforce development, intellectual property and other matters.
Mr. Peterson provides mentorship support to CEOs and Founders of early-stage and emerging companies, and served on the University of Texas MD Anderson Cancer Center’s Board of Advisors for the Center for Professional Development and Entrepreneurship. He served on the Board and continues to assist SanGlobal Ed Corp. (dba Myverse, now TokuOra), a teen and collegiate personal and professional development resource, enabled with social media on web and mobile platforms. He continues to advise and assist TIGAR Health in introducing their remarkable multi-marker physician decision support breakthrough in detection and management of diabetes spectrum and related disease conditions.
He has lived and worked overseas for 18 years, in the Middle East, Europe and Africa, and is Chair Emeritus of the American International School of Johannesburg. He was President and a long-serving Board member of the San Carlos Tennis Club (a USTA Community Tennis Association) and has provided volunteer tennis coaching to train 50 new players. He is an avid skier and is an active volunteer with Bay Area Ski Bus (now Tahoe Ski Trips).
Mr. Peterson is married to a high tech and internet marketing entrepreneur, now focused on small animal care and advocacy. He has three children, now joined by spouses and two (marvelous) grandchildren!